Integrative molecular bioinformatics study of human adrenocortical tumors: MicroRNA, tissue-specific target prediction, and pathway analysis

Endocrine-Related Cancer

Volumn 16, Issue 3, 2009, Pages 895-906

  Tömböl, Zsófia ^a   Szabó, Peter M ^a   Molnár, Viktor ^a   Wiener, Zoltán ^a   Tölgyesi, Gergely ^a   Horányi, János ^a   Riesz, Peter ^a   Reismann, Peter ^a   Patócs, Attila ^a   Likó, István ^b   Gaillard, Rolf Christian ^c   Falus, András ^a   Rácz, Károly ^a   Igaz, Peter ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b GEDEON RICHTER LTD   (Hungary)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 184; MICRORNA 210; MICRORNA 214; MICRORNA 503; MICRORNA 511; UNCLASSIFIED DRUG;

ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX TUMOR; ADULT; ARTICLE; BIOINFORMATICS; CARCINOGENESIS; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE INTERACTION; GENE TARGETING; HUMAN; HUMAN TISSUE; HYDROCORTISONE RELEASE; INFORMATION PROCESSING; MALE; MICROARRAY ANALYSIS; PREDICTION; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS;

ADENOMA; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ADULT; ALGORITHMS; COMPUTATIONAL BIOLOGY; DRUG DELIVERY SYSTEMS; FEMALE; FORECASTING; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MODELS, BIOLOGICAL; ORGAN SPECIFICITY; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 72749126286     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-09-0096     Document Type: Article

References (44)

1. Ambros V, Bartel B, Bartel DP, Burge CB, Carrington JC, Chen X, Dreyfuss G, Eddy SR, Griffiths-Jones S, Marshall M et al. 2003 A uniform system for microRNA annotation. RNA 9 277-279.
2. Baek D, Villén J, Shin C, Camargo FD, Gygi SP & Bartel DP 2008 The impact of microRNAs on protein output. Nature 455 64-71.
3. Barbarotto E, Schmittgen TD & Calin GA 2008 MicroRNAs and cancer: profile, profile, profile. International Journal of Cancer 122 969-977.
4. Bernini GP, Moretti A, Bonadio AG, Menicagli M, Viacava P, Naccarato AG, Iacconi P, Miccoli P & Salvetti A 2002 Angiogenesis in human normal and pathologic adrenal cortex. Journal of Clinical Endocrinology and Metabolism 87 4961-4965. (Pubitemid 35316333)
5. Bottoni A, Zatelli MC, Ferracin M, Tagliati F, Piccin D, Vignali C, Calin GA, Negrini M, Croce CM & Degli Uberti EC 2007 Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. Journal of Cellular Physiology 210 370-377. (Pubitemid 44956882)
6. KIP2 are involved in proliferation of malignant sporadic adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism 85 322-330.
7. Brown JW, Prieto LM, Perez-Stable C, Montoya M, Cappell S & Fishman LM 2008 Estrogen and progesterone lower cyclin B1 and D1 expression, block cell cycle in G2/M, and trigger apoptosis in human adrenal carcinoma cell cultures. Hormone and Metabolic Research 40 306-310. (Pubitemid 351859440)
8. Bueno MJ, de Castro IP & Malumbres M 2008 Control of cell proliferation pathways by microRNAs. Cell Cycle 7 3143-3148.
9. Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, Sheldon H, Harris AL, Gleadle JM & Ragoussis J 2008 Hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clinical Cancer Research 14 1340-1348.
10. Cerquetti L, Bucci B, Marchese R, Misiti S, De Paula U, Miceli R, Muleti A, Amendola D, Piergrossi P, Brunetti E et al. 2008 Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines. Endocrine-Related Cancer 15 623-634. (Pubitemid 351880848)
11. Chen CZ 2005 MicroRNAs as oncogenes and tumor suppressors. New England Journal of Medicine 353 1768-1771.
12. Chen Y & Stallings RL 2007 Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Research 67 976-983. (Pubitemid 46270752)
13. Cheng AM, Byrom MW, Shelton J & Ford LP 2005 Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Research 33 1290-1297. (Pubitemid 41439922)
14. Egloff AM, Vella LA & Finn OJ 2006 Cyclin B1 and other cyclins as tumor antigens in immunosurveillance and immunotherapy of cancer. Cancer Research 66 6-9.
15. Gennarino VA, Sardiello M, Avellino R, Meola N, Maselli V, Anand S, Cutillo L, Ballabio A & Banfi S 2009 MicroRNA target prediction by expression analysis of host genes. Genome Research 19 481-490.
16. Giordano TJ, Kuick R, Else T, Gauger PG, Vinco M, Bauersfeld J, Sanders D, Thomas DG, Doherty G & Hammer G 2009 Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clinical Cancer Research 15 668-676.
17. Griffiths-Jones S, Saini HK, van Dongen S & Enright AJ 2008 miRBase: tools for microRNA genomics. Nucleic Acids Research 36 D154-D158.
18. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP & Bartel DP 2007 MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Molecular Cell 27 91-105. (Pubitemid 46991392)
19. Grosshans H & Filipowicz W 2008 Proteomics joins the search for microRNA targets. Cell 134 560-562.
20. Huang JC, Babak T, Corson TW, Chua G, Khan S, Gallie BL, Hughes TR, Blencowe BJ, Frey BJ & Morris QD 2007 Using expression profiling data to identify human microRNA targets. Nature Methods 4 1045-1049. (Pubitemid 350201777)
21. Hulshizer R & Blalock EM 2007 Post hoc pattern matching: assigning significance to statistically defined expression patterns in single channel microarray data. BMC Bioinformatics 8 240. (Pubitemid 47208686)
22. Igaz P, Wiener Z, Szabo P, Falus A, Gaillard RC, Horanyi J, Racz K & Tulassay Z 2006 Functional genomics approaches for the study of sporadic adrenal tumor pathogenesis: clinical implications. Journal of Steroid Biochemistry and Molecular Biology 101 87-96. (Pubitemid 44322042)
23. Koch CA, Pacak K & Chrousos GP 2002 The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors. Journal of Clinical Endocrinology and Metabolism 87 5367-5384.
24. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M et al. 2005 Combinatorial microRNA target predictions. Nature Genetics 37 495-500.
25. Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S & Zucman-Rossi J 2008 MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 47 1955-1963. (Pubitemid 351952843)
26. Libè R, Fratticci A & Bertherat J 2007 Adrenocortical cancer: pathophysiology and clinical management. Endocrine-Related Cancer 14 13-28. (Pubitemid 47521719)
27. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS & Johnson JM 2005 Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433 769-773. (Pubitemid 40292988)
28. -ΔΔCt method. Methods 25 402-408.
29. Lombardi CP, Raffaelli M, Pani G, Maffione A, Princi P, Traini E, Galeotti T, Rossi ED, Fadda G & Bellantone R 2006 Gene expression profiling of adrenal cortical tumors by cDNA macroarray analysis. Results of a preliminary study. Biomedicine & Pharmacotherapy 60 186-190.
30. Mertens-Talcott SU, Chintharlapalli S, Li X & Safe S 2007 The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2/M checkpoint in MDA-MB-231 breast cancer cells. Cancer Research 67 11001-11011. (Pubitemid 350145930)
31. Molinari M 2000 Cell cycle checkpoints and their inactivation in human cancer. Cell Proliferation 33 261-274. (Pubitemid 30807736)
32. Pavlidis P 2003 Using ANOVA for gene selection from microarray studies of the nervous system. Methods 31 82-89.
33. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM & Cohn DE 2009 The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecologic Oncology 112 55-59.
34. Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S, Calin GA, Volinia S, Liu CG, Scarpa A et al. 2006 MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. Journal of Clinical Oncology 24 4677-4684. (Pubitemid 46630931)
35. Selbach M, Schwanhäusser B, Thierfelder N, Fang Z, Khanin R & Rajewsky N 2008 Widespread changes in protein synthesis induced by microRNAs. Nature 455 58-63.
36. Soon PS, McDonald KL, Robinson BG & Sidhu SB 2008 Molecular markers and the pathogenesis of adrenocortical cancer. Oncologist 13 548-561. (Pubitemid 351872872)
37. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES et al. 2005 Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. PNAS 102 15545-15550. (Pubitemid 41528093)
38. Taylor WR & Stark GR 2001 Regulation of the G2/M transition by p53. Oncogene 20 1803-1815.
39. Weber F, Teresi RE, Broelsch CE, Frilling A & Eng C 2006 A limited set of human microRNA is deregulated in follicular thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 91 3584-3591. (Pubitemid 44402141)
40. Wijnhoven BP, Michael MZ & Watson DI 2007 MicroRNAs and cancer. British Journal of Surgery 94 23-30.
41. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP & Wei WI 2008 Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clinical Cancer Research 14 2588-2592.
42. Yan X, Chua MS, He J & So SK 2008 Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo. Molecular Cancer 7 19.
43. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV et al. 2008 MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Research 68 425-433.
44. Zhao JJ, Yang J, Lin J, Yao N, Zhu Y, Zheng J, Xu J, Cheng JQ, Lin JY & Ma X 2009 Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Child's Nervous System 25 13-20.